3 edition of Management of ovarian cancer found in the catalog.
Includes bibliographies and index.
|Statement||[edited by] George Blackledge, K.K. Chan.|
|Contributions||Blackledge, George., Chan, K. K.|
|LC Classifications||RC280.O8 M36 1986|
|The Physical Object|
|Pagination||214 p. :|
|Number of Pages||214|
|LC Control Number||86013722|
Epithelial ovarian cancer is a cancer of older women. In fact, almost half of women diagnosed with ovarian cancer will be older than and 25% will be older than age Therefore, it is crucial to examine the available data in older populations to optimize the therapeutic approach without negatively affecting the quality of life permanently. Unfortunately, little prospective data are Cited by: 2. Breast & Ovarian Cancer Information & Research - Risk Management: Ovarian Cancer Screening | FORCE is a national nonprofit organization devoted to improving the lives of people and families affected by hereditary breast and ovarian cancer. Our mission includes support, education, advocacy, awareness, and research and our programs serve anyone with a BRCA mutation or a family history of cancer.
The UK trial found a small reduction in ovarian deaths from CA, and transvaginal ultrasound for routine population-based screening for ovarian cancer. However, the results are regarded as preliminary, requiring confirmation and longer follow-up and, in the meantime, the US Preventive Services Task Force (USPSTF) recommends against. The book is written in reader-friendly style and is suitable for anyone wishing to learn more about ovarian cancer, from medical students and housestaff, to practitioners, healthcare support staff.
Management of Recurrent or Persistent Ovarian Cancer disease at the completion of chemotherapy. The role of secondary cytoreductive surgery for persistent and/or recurrent disease remains un clear. Complete response to chemotherapy for recurrent ovarian cancer is rare, and shrinkage of the tumor does not always prolongs. Ovarian cancer is when abnormal cells in the ovary begin to grow and divide in an uncontrolled way, and eventually form a growth (tumour). If not caught early cancer cells gradually grow into the surrounding tissues and may spread to other areas of the body. There are different types of ovarian cancer. The type depends on the type of cell the.
Renaissance and Mannerist art
Soil survey of Vernon County, Missouri
Blood flow through organs and tissues;
Sun Sisters and Lightning Brothers (Australasian Drama Studies, 37)
A portfolio of business jokes
The First Amendment and the fourth estate
Excel 5 for Macintosh
heroine of the north
Garlands Bankruptcy Bulletin
Tonga agricultural census 2001.
Excerpt. These clinical guidelines review a number of clinical questions that involve the detection, diagnosis and initial management of ovarian cancer and which focus on areas of uncertainty or where there is a wide variation in clinical practice.
It is intended for basic scientists and clinicians who have questions surrounding the issues Management of ovarian cancer book ovarian cancer.
This outstanding and readable book covers many of the basic science and translational science issues involved in ovarian cancer.” (David.
Familial Breast and Ovarian Cancer is an excellent introduction to the genetics of breast and ovarian cancer. The book is a collection of chapters by investigators in clinical, epidemiologic, and molecular science from Europe and Canada, with substantial contributions from researchers in the United cturer: Cambridge University Press.
Addresses difficult problems of ovarian cancer management and detection Provides specific and personal guidance from the experts Comments on the book proposal include: David Gershenson is an extremely well respected gynecologic oncologist and surgeon who has edited a Cited by: Morrison et al., () conducted a Cochrane review of chemotherapy versus surgery for the initial treatment of advanced ovarian cancer.
Despite an extensive search of the literature, the authors identified only one small RCT which had randomised 85 women to receive either one cycle of chemotherapy followed by embolisation of the ovarian artery, debulking surgery and adjuvant chemotherapy or.
Cancer is a chronic disease, and like any other chronic medical condition, cancer patients have families, jobs, businesses and other commitments. Therefore, our aim is to cure the cancer if possible, and if not curable, then control the symptoms to improve quality of life and prolong the person's life by a few months (for example 2, 3, 6, Additional Physical Format: Online version: Management of ovarian cancer.
London ; Boston: Butterworths, (OCoLC) Online version: Management of ovarian cancer. Intestinal obstruction in advanced ovarian cancer -- Ch. Management of an isolated recurrent pelvic mass -- Ch. Symptomless rise in CA -- Ch. Interpretation of asymptomatic elevation of CA -- Ch.
Ovarian cancer with a family history -- Ch. Living with ovarian cancer -. For the management of abnormal cervical screening tests and cancer precursors: updated consensus guidelines for the management of abnormal cervical cancer screening tests and cancer precursors.
J Low Genit Tract Dis ;17(5 Suppl 1):S1-S Ovarian Cancer: Advances in Diagnosis and Management presents unique international perspectives on this devastating disease. While ovarian cancer has mainly been considered a disease of the Western hemisphere, this book moves beyond our conventional understanding and embraces knowledge from around the world.
Ovarian cancer management is a rapidly changing field with new treatment agents available as a result of a greater understanding of the pathogenesis of this disease.
In addition, both surgical and chemotherapeutic treatment strategies are evolving to maximise response in this disease. This book brings together leading specialists from around the world to discuss and outline a variety of new Author: Omer Devaja, Andreas Papadopoulos.
Ovarian Cancer is a combination of two separate but complementary initiatives. One initiative was a series of reviews commissioned to cover the spectrum of clinical management of ovarian cancer from prevention, screening, and diagnosis to surgery, chemotherapy, and palliative care.
The second initiative has been coordinated by the Helene Harris Memorial Trust (HHMT), which organises Cited by: 1. Cancer of the ovary is not common, but it causes more deaths than other female reproductive cancers. The sooner ovarian cancer is found and treated, the better your chance for recovery.
But ovarian cancer is hard to detect early. Women with ovarian cancer may have no symptoms or just mild symptoms until the disease is in an advanced stage. This book provides an overview of the latest developments in the concepts and management of ovarian cancer.
The new data presented throughout opens the way to radically different therapeutic approaches. Ovarian cancer provides an up-to-date and comprehensive synthesis of clinical management and research progress in the field of epithelial ovarian cancer.
The book has its origins in two separate but complementary initiatives. One initiative was a series of reviews commissioned to cover the spectrum of clinical management of ovarian cancer from prevention, screening and diagnosis to surgery.
without a history of ovarian cancer, or if there is one third-degree relative with breast and/or ovarian cancer and two or more other close blood rela - tives with breast cancer (at least one 50 Cited by: The hypothesis on the pathogenesis of epithelial ovarian cancer continues to evolve.
Although epithelial ovarian cancer had been assumed to arise from the coelomic epithelium of the ovarian surface, it is now becoming clearer that the majority of serous carcinomas arise from epithelium of the distal fallopian tube, whereas clear cell and endometrioid cancers arise from endometriosis.
Molecular Cited by: 4. According to the National Comprehensive Cancer Network (NCCN) ovarian cancer guidelines, in newly diagnosed invasive epithelial ovarian cancer that involves the pelvis and upper abdomen, residual disease of less than 1 cm is evidence of optimal cytoreduction, although the greatest possible effort should be made to remove all obvious disease.
 The NCCN notes that one or more of. Ovarian cancer treatment requires a gynecological oncologist and surgeon who will remove the ovarian cancer using the protocol of cytoreductive surgery. Ref.1 is very explicit on this: “Formal residency programs in obstetrics and gynecology and general surgery do not usually provide the depth of knowledge and experience needed for the.
Practical, authoritative, and highly-illustrated, this volume in the brand new Early Detection and Treatment of Cancer series covers current protocols and the latest advances in diagnostic imaging and molecular and serologic markers for ovarian cancer.
An international group of authors focus on management controversies and present sections on complications of cancer treatment, surgical techniques, and symptom management. Additional coverage addresses the psychological impact of cancer diagnosis, fertility and gynecologic cancer, and quality of .Updated and expanded, the third edition of Surgery for Ovarian Cancer focuses on essential techniques for the effective management of ovarian cancer.
It reflects the most contemporary science and surgical applications for the management of patients with ovarian cancer and .Updated and expanded, the third edition of Surgery for Ovarian Cancer focuses on essential techniques for the effective management of ovarian reflects the most contemporary science and surgical applications for the management of patients with ovarian cancer and Cited by: 3.